Critics Demanded Changes to mRNA Vaccine Policies
More than 100 signatories urged Robert F. Kennedy Jr. to address vaccine platform concerns in an open letter.
Updated on Sept. 21, 2026 in COVID-19
Live Poll
Do you trust federal health agencies and the pharmaceutical industry to oversee national vaccine policy?
Critics, including Tucker Carlson and Marjorie Taylor Greene, sent an open letter to Robert F. Kennedy Jr. objecting to ongoing mRNA vaccine policies. The letter suggests a widening rift between political movements regarding federal health priorities.
Why it matters
The letter highlights growing friction over administration health policies, with critics arguing that the focus should shift away from the mRNA platform. Signatories expressed concerns that policy goals have strayed from promises regarding medical accountability.
An FDA assessment identified 10 children's deaths potentially attributable to the COVID vaccine. Meanwhile, current estimates indicate that only 9.7% of children have received a COVID vaccine this year.
The players
Robert F. Kennedy Jr.
He is a prominent political figure currently overseeing federal health policy initiatives.
Mary Talley Bowden
She serves as the president of Americans for Health Freedom and organized the open letter.
Tucker Carlson
He is a well-known media commentator and political activist who signed the open letter.
Marjorie Taylor Greene
She is a member of the United States Congress and an active signatory to the letter.
Thomas Massie
He is a U.S. Representative from Kentucky who participated in the opposition letter.
The details
Organized by Mary Talley Bowden of Americans for Health Freedom, the letter claims the administration performed a bait and switch on its policy goals. Signatories including Thomas Massie cite concerns over the $1.24 billion Pfizer contract and the extension of PREP Act protections through 2029.
Timeline
February 2026: The FDA rejected initial data for Moderna's mRNA flu shot.
May 2026: Marty Makary resigned from his role as FDA commissioner.
August 2026: The FDA authorized Moderna's mRNA flu shot via accelerated approval.
September 21, 2026: Critics sent the open letter to Robert F. Kennedy Jr.
December 31, 2029: The PREP Act liability protection expires.
The Big Picture
This story follows a pattern set by the PREP Act declaration, which remains the central legal pillar for COVID-19 liability protections. Critics are now challenging the long-term extension of this framework through 2029 as part of a broader critique of federal vaccine strategies.
The ongoing debate over mRNA platform safety and vaccine mandates affects public confidence in federal health recommendations. Patients may face continued uncertainty regarding the scope of liability protections for medical countermeasures.
The takeaway
Public polling indicates that 90% of voters express low trust in the pharmaceutical industry, suggesting a deep skepticism regarding current procurement contracts. Addressing these sentiments remains a significant challenge for officials balancing public health mandates with political accountability.
Further reading
For more information on current federal guidance, visit the COVID-19 section.
Live Poll
Do you trust federal health agencies and the pharmaceutical industry to oversee national vaccine policy?
